Ross River Virus: Epidemic Polyarthritis

Vaccines for Biodefense and Emerging and Neglected Diseases

Volumn , Issue , 2009, Pages 631-644

  Aaskov, John ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884454671     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-369408-9.00034-2     Document Type: Chapter

References (130)

1. Aaskov J.G. RRV disease. Arbovirus Research in Australia. Proceedings of the Second Symposium 1979, Vol. 2:164-167. CSIRO, Brisbane. T.D. St. George, E.L. French (Eds.).
2. Aaskov J.G., Chen J.Y., Hanh T.H., Dennington P.M. Surveillance for RRV infection using blood donors. Am. J. Trop. Med. Hyg. 1998, 58:726-730.
3. Aaskov J.G., Dalglish D.A., Harper J.J., Douglas J.F., Donaldson M.D., Hertzog P.J. Natural killer cells in viral arthritis. Clin. Exp. Immunol. 1987, 68:23-32.
4. Aaskov J.G., Davies C.E.A., Tucker M., Dalglish D.A. Effect on mice of infection during pregnancy with three Australian arboviruses. Am. J. Trop. Med. Hyg. 1981, 30:198-203.
5. Aaskov J.G., Doherty R.L. Arboviral zoonoses of Australasia. Handbook of Zoonoses 1994, 301-317. CRC Press, Boca Raton, FL. 2nd ed. W. Beran (Ed.).
6. Aaskov J.G., Fraser J.R.E., Dalglish D.A. Specific and non-specific immunological changes in epidemic polyarthritis patients. Aust. J. Exp. Biol. Med. Sci. 1981, 59:599-608.
7. Aaskov J.G., Mataika J.U., Lawrence G.W., Rabukawaqa V., Tucker M.M., Miles J.A.R., Dalglish D.A. An epidemic of RRV infection in Fiji, 1979. Am. J. Trop. Med. Hyg. 1981, 30:1053-1059.
8. Aaskov J.G., Nair K., Lawrence G.W., Dalglish D.A., Tucker M. Evidence for transplacental transmission of RRV in humans. Med. J. Aust. 1981, 2:20-21.
9. Aaskov J.G., Ross P., Davies C.E.A., Innis M.D., Guard R.W., Stallman N.D., Tucker M. Epidemic polyarthritis in north-eastern Australia, 1978-1979. Med. J. Aust. 1981, 2:17-19.
10. Aaskov J.G., Ross P.V., Harper J.J., Donaldson M.D. Isolation of RRV from epidemic polyarthritis patients in Australia. Aust. J. Exp. Biol. Med. Sci. 1985, 63:587-597.
11. Aaskov J., Tucker M. Ultraviolet inactivation of RRV for use in haemagglutination inhibition studies. Aust. J. Med. Technol. 1979, 10:109-111.
12. Aaskov J.G., Williams L., Yu S. A candidate RRV vaccine: pre-clinical evaluation. Vaccine 1997, 15:1396-1404.
13. Aleck K.A., Rosen L., Pettitt D.J., Boveington C., Bennett P.H. Absence of intrauterine infection following RRV infection during pregnancy. Am. J. Trop. Med. Hyg. 1983, 32:618-620.
14. Anderson S.G., Doherty R.L., Carley J.G. Epidemic polyarthritis: antibody to a group A arthropod borne virus in Australia and the island of New Guinea. Med. J. Aust. 1961, 1:273-276.
15. Anderson S.G., French E.L. An epidemic exanthem associated with polyarthritis in the Murray Valley, 1956. Med. J. Aust. 1957, 2:113-117.
16. Anstey N., Currie B., Tai K.S. RRV disease presenting with hematuria. Southeast Asian J. Trop. Med. Public Health 1991, 22:281-283.
17. Azoulas J.K., Wishart E., Bibby S., Ainsworth C. Isolation of RRV from mosquitoes and from horses with signs of musculo-skeletal disease. Aust. Vet. J. 2003, 81:344-347.
18. Barrett A.D.T., Hunt N., Dimmock N.J. A rapid method for the inactivation of virus infectivity prior to assay for interferons. J. Virol. Methods 1984, 8:349-351.
19. Barteling S.J., Vreeswijk J. Developments in foot and mouth vaccines. Vaccine 1991, 9:75-88.
20. Bennett N.M., Cunningham A.L., Fraser J.R.E., Speed B.R. Epidemic polyarthritis acquired in Fiji. Med. J. Aust. 1980, 1:316-317.
21. Boutwell R.K., Colburn N.H., Muckerman C.C. In vivo reactions of beta propiolactone. Ann. N.Y. Acad. Sci. 1969, 163:751-764.
22. Casals J. The arthropod borne group of animal viruses. Trans. N.Y. Acad. Sci. 1957, 19:219-235.
23. Cheng R.H., Kuhn R.J., Olson N.H., Rossman M.G., Choi H.K., Smith T.J., Baker T.S. Nucleocapsid and glycoprotein organisation in an enveloped virus. Cell 1995, 80:621-630.
24. Clarris B.J., Doherty R.L., Fraser J.R.E., French E.L., Muirden K.D. Epidemic polyarthritis: a cytological, virological and immunological study. Aust. N.Z. J. Med. 1975, 5:450-457.
25. Cole F.E., May S.W., Eddy G.A. Inactivated Venezeulan equine encephalomyelilitis vaccine prepared from attenuated (TC-83 strain) virus. Appl. Microbiol. 1974, 27:150-153.
26. Condon R.J., Rouse I.L. Acute symptoms and sequelae or RRV infection in South-Western Australia: a follow up study. Clin. Diag. Virol. 1995, 3:273-284.
27. Cunningham A.L., Fraser J.R.E. RRV infection of human synovial cells in vitro. Aust. J. Exp. Biol. Med. Sci. 1985, 63:197-204.
28. Curran M., Harvey B., Crerar S., Oliver G., D'Souza R., Myint H., Rann C., Andrews R. Australia's notifiable diseases status, 1996. Annual Report of the National Notifiable Diseases Surveillance System. Commun. Dis. Intell. 1997, 21:281-307.
29. Dalgarno L., Rice C.M., Strauss J.H. RRV 26s RNA: complete nucleotide sequence and deduced sequence of the encoded structural proteins. Virology 1983, 129:170-187.
30. Davies D.J., Moran J.E., Niall J.F., Ryan G.B. Segmental necrotising glomerulonephritis with anti-neutrophil antibody: possible arbovirus aetiology. Br. Med. J. 1982, 285:606.
31. Doherty R.L. Arboviruses of Australia. Aust. Vet. J. 1972, 48:172-180.
32. Doherty R.L., Barrett W.J., Gorman B.M., Whitehead R.H. Epidemic polyarthritis in eastern Australia. Med. J. Aust. 1971, 1:5-8.
33. Doherty R.L., Carley J.G., Best J.C. Isolation of RRV from man. Med. J. Aust. 1972, 1:1083-1084.
34. Doherty R.L., Gorman B.M., Whitehead R.H., Carley J.G. Studies of epidemic polyarthritis: the significance of three group A arboviruses isolated from mosquitoes in Queensland. Australas. Ann. Med. 1964, 13:322-327.
35. Doherty R.L., Gorman B.M., Whitehead R.H., Carley J.G. Studies of arthropod borne virus infections in Queensland. V. Survey of antibodies to group A arboviruses in man and other animals. Aust. J. Exp. Biol. Med. Sci. 1966, 44:365-378.
36. Doherty R.L., Whitehead R.H., Gorman B.M., O'Gower A.K. The isolation of a third Group A arbovirus in Australia with preliminary observations on its relationship to epidemic polyarthritis. Aust. J. Sci. 1963, 26:183-184.
37. Dowling P.G. Epidemic polyarthritis. Med. J. Aust. 1946, 1:245-246.
38. 1. Prevalence of antibodies, December, 1974. Med. J. Aust. 1976, 1:257-259. Echuca-Melbourne Collaborative Group Arbovirus infection in a Murray Valley community.
39. Faragher S.G., Marshall I.D., Dalgarno L. RRV genetic variants in Australia and the Pacific Islands. Aust. J. Exp. Biol. Med. Sci. 1985, 63:473-488.
40. Faragher S.G., Meek A.D.J., Rice C.M., Dalgarno L. Genome sequences of a mouse avirulent and a mouse virulent strain of RRV. Virology 1988, 163:509-526.
41. Fauran P., Donaldson M., Harper J., Oseni R.A., Aaskov J.G. Characterisation of RRVes isolated from patients with polyarthritis in New Caledonia and Wallis and Futuna Islands. Am. J. Trop. Med. Hyg. 1984, 33:1228-1231.
42. Fraser J.R.E. Epidemic polyarthritis and RRV disease. Clin. Rheum. Dis. 1986, 12:369-388.
43. Fraser J.R.E., Becker G.J. Mononuclear cell types in chronic synovial effusions of RRV disease. Aust. N.Z. J. Med. 1984, 14:505-506.
44. Fraser J.R.E., Christie D.G., Gust I.D., White J., Leach R., Macaulay E.D., Ahern A.P., Alexander J., Jones J.M., Lung D.Y.L., Moore F.M., Moysey C.D., Phillips P.J., Pryor I. Arbovirus infection in a Murray Valley community. Aust. N.Z. J. Med. 1986, 16:52-57.
45. Fraser J.R.E., Cunningham A.L. Incubation time of epidemic polyarthritis. Med. J. Aust. 1980, 1:550-551.
46. Fraser J.R.E., Cunningham A.L., Clarris B.J., Aaskov J.G., Leach R. Cytology of synovial effusions in epidemic polyarthritis. Aust. N.Z. J. Med. 1981, 11:168-173.
47. Fraser J.R.E., Cunningham A.L., Mathews J.D., Riglar A. Immune complexes and RRV disease (epidemic polyarthritis). Rheumatol. Int. 1988, 8:113-117.
48. Fraser J.R.E., Cunningham A.L., Muller H.K., Sinclair R.A., Standish H.G. Glomerulonephritis in the acute phase of RRV disease (epidemic polyarthritis). Clin. Nephrol. 1988, 29:149-152.
49. Fraser J.R.E., Ratnamohan V.M., Dowling J.P.G., Becker C.J., Varigos C.A. The exanthem of RRV infection: histology, location of virus antigen and nature of inflammatory infiltrate. J. Clin. Pathol. 1983, 36:1256-1263.
50. Fraser J.R.E., Rowley M.J., Tait B. Collagen antibodies in RRV disease (epidemic polyarthritis). Rheumatol. Int. 1987, 7:267-269.
51. Fraser J.R.E., Tait B., Aaskov J.G., Cunningham A.L. Possible genetic determinants in epidemic polyarthritis caused by RRV infection. Aust. N.Z. J. Med. 1980, 10:597-603.
52. Fuller C.O., Warner P. Some epidemiological and laboratory observations on an epidemic rash and polyarthritis occurring in the upper Murray region of south Australia. Med. J. Aust. 1957, 2:117-120.
53. Gard G.P., Marshall I.D., Walker K.H., Ackland H.M., De Sarem W.G. Association of Australian arboviruses with nervous disease in horses. Aust. Vet. J. 1977, 53:61-66.
54. Goswell G. A further report on an epidemic of acute polyarthritis. Med. J. Aust. 1946, 2:861-863.
55. Gubler D.J. Transmission of RRV by Aedes polynesiensis and Aedes aegypti. Am. J. Trop. Med. Hyg. 1981, 30:1303-1306.
56. Halliday J.H., Horan J.P. An epidemic of polyarthritis in the Northern Territory. Med. J. Aust. 1943, 2:293-295.
57. Harley D., Sleigh A., Ritchie S. RRV transmission, infection and disease: a cross-disciplinary review. Clin. Microbiol. Rev. 2001, 14:909-932.
58. Harris L. Polyarthritis in the Northern Territory. Med. J. Aust. 1944, 1:546.
59. Harrison V.R., Eckels K.H., Bartelloni P.J., Hampton C. Production and evaluation of a formalin killed chikungunya vaccine. J. Immunol. 1971, 107:643-647.
60. Harley D., Sleigh A., Ritchie S. Ross River virus transmission, infection, and disease: a disciplinary review. Clin. Microbiol. Rev. 2001, 14:909-932.
61. Hawkes R.A., Boughton C.R., Nairn H.M., Stallman N.D. A major outbreak of epidemic polyarthritis in New South Wales during the summer of 1983/1984. Med. J. Aust. 1985, 143:330-333.
62. Hazelton R.A., Hughes C., Aaskov J.G. The inflammatory response in the synovium of a patient with Ross River arbovirus infection. Aust. N.Z. J. Med. 1985, 15:336-339.
63. Heil M.L., Albee A., Strauss J.H., Kuhn R.J. An amino acid substitution in the coding region of the E2 glycoprotein adapts RRV to utilise heparin sulphate as an attachment moiety. J. Virol. 2001, 75:6303-6309.
64. Journeaux S.F., Brown W.G., Aaskov J.G. Prolonged infection of human synovial cells with RRV. J. Gen. Virol. 1987, 68:3165-3169.
65. Kay, B.H. Assignment Report, World Health Organisation, Regional Office for the South Pacific, Manila, 1981.
66. Kay B.H., Aaskov J.G. RRV disease (epidemic polyarthritis). The Arboviruses: Epidemiology and Ecology 1989, Vol. IV:93-112. CRC Press, Boca Raton, FL. T.P. Monath (Ed.).
67. Kay B.H., Hall R.A., Fanning I.D., Mottram P., Young P.L., Pollitt C.C. Experimental infection of vertebrates with Murray Valley encephalitis and RRVes. Arbovirus Research in Australia: Proceedings, Fourth Symposium 1986, 71-75. CSIRO, Brisbane. T.D. St George, B.H. Kay, J. Blok (Eds.).
68. Keary P.J., Soden M.A.M., Mudge P.R. The changing epidemiology of RRV disease in South Australia. Med. J. Aust. 1997, 166:333.
69. Kerr P.J., Fitzgerald S., Tregear G.W., Dalgarno L., Weir R.C. Characterisation of a major neutralisation domain of RRV using anti-viral and anti-peptide antibodies. Virology 1992, 187:338-342.
70. Kerr P.J., Weir R.C., Dalgarno L. RRV variants selected during passage in chick embryo fibroblasts: serological, genetic and biological changes. Virology 1993, 193:446-449.
71. Kistner O., Barrett N., Bruhmann A., Reiter M., Mundt W., Savidis-Dacho H., Schrober-Bendixen S., Dorner F., Aaskov J.G. The pre-clinical testing of a formaldehyde inactivated RRV vaccine designed for use in humans. Vaccine 2007, 25:4845-4852.
72. Klapsing P., MacLean J.D., Glaze S., McClean K.L., Drebot M.A., Lanciotti R.S., Campbell G.J. RRV disease re-emergence, Fiji, 2003-2004. Emerg. Infect. Dis. 2005, 11:613-615.
73. Klockmann U., Bock H.L., Franke V., Hein B., Reiner G., Hilfenhaus J. Preclinical investigations of the safety, immunogenicity and efficacy of a purified inactivated tick-borne encephalitis vaccine. J. Biol. Standards 1989, 17:331-342.
74. Lanciotti R.S., Ludwig M.L., Rwaguma E.B., Lutwama J.J., Kram T.M., Karabatsos N., Cropp B.C., Miller B.R. Emergence of epidemic O'nyong-nyong fever in Uganda after a 35 year absence: genetic characterisation of the virus. Virology 1998, 252:258-268.
75. Lidbury B.A., Mahalingam S. Specific ablation of anti-viral gene expression in macrophages by antibody-dependent enhancement of RRV infection. J. Virol. 2000, 74:8376-8381.
76. Linn M.L., Aaskov J.G., Suhrbier A. Antibody dependent enhancement and persistence in macrophages of an arbovirus associated with arthritis. J. Gen. Virol. 1996, 77:407-411.
77. Linn M.L., Mateo L., Gardiner J., Suhrbier A. Alphavirus-specific cytotoxic T lymphocytes recognise a cross-reactive epitope from the capsid protein and can eliminate virus from persistently infected macrophages. J. Virol. 1998, 72:5146-5153.
78. Lucas R.E., Qiao M. A case of encephalitis in central Australia due to RRV?. Aust. N.Z. J. Med. 1999, 29:268-270.
79. Marshall I.D., Miles J.A.R. RRV and epidemic polyarthritis. Curr. Top. Vector Res. 1984, 2:31-56.
80. Martin J.H.B., Weir R.C., Dalgarno L. Replication of standard and defective RRV in BHK cells: patterns of viral RNA and polypeptide synthesis. Arch. Virol. 1979, 61:87-103.
81. Mateo L., Linn M.L., McColl S.R., Cross S., Gardiner J., Suhrbier A. An arthrogenic alphavirus induces monocyte chemoattractant protein-1 and interlukin-8. Intervirology 1999, 43:55-60.
82. Meek A.D., Faragher S.G., Weir R.C., Dalgarno L. Genetic and phenotypic studies on RRV variants of enhanced virulence selected during mouse passage. Virology 1989, 172:399-407.
83. Milner A.R., Marshall I.D. Pathogenesis of in utero infections with abortogenic and non abortogenic alphaviruses in mice. J. Virol. 1984, 50:66-72.
84. Mims C.A., Murphy F.A., Taylor W.P., Marshall I.D. Pathogenesis of RRV infection in mice. I. Ependymal infection, cortical thinning, and hydrocephalus. J. Infect. Dis. 1973, 127:121-128.
85. Mitchell C.J., Miller B.R., Gubler D.J. Vector competence of Aedes albopictus from Houston, Texas, for dengue serotypes 1 to 4, yellow fever and RRVes. J. Am. Mosquito Control Assoc. 1987, 3:460-465.
86. Mudge P.R., Aaskov J.G. Epidemic polyarthritis in Australia, 1980-1981. Med. J. Aust. 1983, 2:269-273.
87. Mukhopadhyay S., Chipman P.R., Hong E.M., Kuhn R.J., Rossmans M.G. In vitro assembled alphavirus core like particles maintain a structure similar to that of nucleocapsid cores in mature viruses. J. Virol. 2002, 76:11128-11132.
88. Murphy F.A., Taylor W.P., Mims C.A., Marshall I.D. Pathogenesis of RRV infection in mice. II. Muscle and brown fat lesions. J. Infect. Dis. 1973, 127:129-138.
89. Mylonas A.D., Brown A.M., Carthew T.L., McGrath B., Purdie D.M., Pandeya N., Vecchio P.C., Collins L.G., Gardiner I.D., de Looze F.J., Reymond E.J., Suhrbier A. Natural history of RRV-induced epidemic polyarthritis. Med. J. Aust. 2002, 177:356-360.
90. Mylonas A.D., Harley D., Purdie D.M., Pandeya N., Vecchio P.C., Farmer J.F., Suhrbier A. Corticosteroid therapy in an alphavirus arthritis. J. Clin. Rheumatol. 2004, 10:326-330.
91. Nimmo J.R. An unusual epidemic. Med. J. Aust. 1928, 1:549-550.
92. Oliveira N.M.M., Broom A.K., Mackenzie J.S., Smith D.W., Lindsay M.D.A., Kay B.H., Hall R.A. Epitope blocking enzyme linked immunosorbent assay for detection of antibodies to RRV in vertebrate sera. Clin. Vaccine Immunol. 2006, 13:814-817.
93. Oseni R.A., Donaldson M.D., Dalglish D.A., Aaskov J.G. Detection by ELISA of IgM antibodies to RRV in serum from patients with suspected epidemic polyarthritis. Bull. World Health Organ. 1983, 61:703-708.
94. Pascoe R.R.R., StGeorge T.D., Cybinski D.H. The isolation of RRV from a horse. Aust. Vet. J. 1978, 54:600.
95. Penna J.E., Irving L.G. Evidence for meningitis in RRV infection. Med. J. Aust. 1993, 159:492-493.
96. Richardson M.A., Boulton R.W., Raghow R.S., Dalgarno L. Polypeptide synthesis in Alphavirus-infected Aedes albopictus cells during the establishment of persistent infection. Arch. Virol. 1980, 63:263-274.
97. Robinson M.C. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features. Trans. R. Soc. Trop. Med. Hyg. 1955, 49:28-32.
98. Rosen L., Gubler D.J., Bennett P.H. Epidemic polyarthritis (Ross River) virus infection in the Cook Islands. Am. J. Trop. Med. Hyg. 1981, 30:1294-1302.
99. Rulli N.E., Suhrbier A., Hueston L., Heise M.T., Tupanceska D., Zaid A., Wilmes A., Gilmore K., Lidbury B.A., Mahalingam S. RRV: molecular and cellular aspects of disease pathogenesis. Pharmacol. Ther. 2005, 107:324-329.
100. Russell R.C. Arboviruses and their vectors in Australia: an update on the ecology and epidemiology of some mosquito-borne arboviruses. Rev. Med. Vet. Entomol. 1995, 83:141-158.
101. Russell R.C. RRV: ecology and distribution. Annu. Rev. Entomol. 2002, 47:1-31.
102. Ryan P.A., Martin L., Mackenzie J.S., Kay B.H. Investigation of grey-headed flying foxes ( Pteropus poliocephalus) (Megachiroptera: Pteropodidae) and mosquitoes in the ecology of RRV in Australia. Am. J. Trop. Med. Hyg. 1997, 57:476-482.
103. Sammels L.M., Coelen R.J., Lindsay M.D., Mackenzie J.S. Geographic distribution and evolution of RRV in Australia and the Pacific Islands. Virology 1995, 212:20-29.
104. Scrimgeour E.M. Suspected RRV encephalitis in Papua New Guinea. Aust. N.Z. J. Med. 1999, 29:559.
105. Scrimgeour E.M., Aaskov J.G., Matz L.R. RRV in Papua New Guinea. Trans. R. Soc. Trop. Med. Hyg. 1987, 81:833-834.
106. Seglenieks Z., Moore B.W. Epidemic polyarthritis in South Australia: report of an outbreak in 1971. Med. J. Aust. 1974, 2:552-556.
107. Seldon S.M., Cameron A.S. Changing epidemiology of RRV disease in South Australia. Med. J. Aust. 1996, 165:313-317.
108. Shope R.E., Anderson S.G. The virus aetiology of epidemic exanthem and polyarthritis. Med. J. Aust. 1960, 1:156-158.
109. Short B. Polyarthritis of unknown origin. Med. J. Aust. 1949, 2:762.
110. Short B. Polyarthritis of unknown origin. Med. J. Aust. 1984, 1:112-119.
111. Sibree E.W. Acute polyarthritis in Queensland. Med. J. Aust. 1944, 2:565-567.
112. Smith T.J., Cheng R.H., Olsen N.H., Peterson P., Chase E., Kuhn R.J., Baker T.S. Putative receptor binding sites on Alphaviruses as visualised by cryoelectron microscopy. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:10648-10652.
113. Soden M., Vasudevan H., Roberst B., Coelen R., Hamlin G., Vasudevan S., La Brooy J. Detection of viral ribonucleic acid and histologic analysis of inflamed synovium in RRV infection. Arthritis Rheum. 2000, 43:365-369.
114. Stanley N.F., Choo S.B. Studies of arboviruses in Western Australia. Serological epidemiology. Bull. World Health Organ. 1964, 30:221-226.
115. Strauss J.H., Strauss E.G. The alphaviruses: gene expression, replication and evolution. Microbiol. Rev. 1994, 58:491-562.
116. Suhrbier A., Linn M.L. Clinical and pathological aspects of arthritis due to RRV and other Alphaviruses. Curr. Opin. Rheumatol. 2004, 16:374-379.
117. Taubman M.A., Atassi M.Z. Reaction of beta-propiolactone with amino acids and its specificity for methionine. Biochem. J. 1968, 106:829-834.
118. Taylor W.P., Marshall I.D. Adaptation studies with RRV: retention of field level virulence. 1. Gen. Virol. 1975, 28:73-83.
119. Tesh R.E., McLean R.G., Shroyer D.A., Calisher C.H., Rosen L. RRV (Togaviridae: Alphavirus) infection (epidemic polyarthritis) in American Samoa. Trans. R. Soc. Trop. Med. Hyg. 1981, 75:426-431.
120. Vrati S., Faragher S.G., Weir R.C., Dalgarno L. RRV mutants with a deletion in the E2 gene: properties of the virion, virus specific macromolecule synthesis and attenuation of virulence for mice. Virology 1986, 151:222-232.
121. Vrati S.C., Fernon C.A., Dalgarno L., Weir R.C. Location of a major antigenic site involved in RRV neutralisation. Virology 1988, 162:346-353.
122. Vrati S., Kerr P.J., Weir R.C., Dalgarno L. Entry kinetics and mouse virulence of RRV mutants altered in neutralisation epitopes. J. Virol. 1996, 70:1745-1750.
123. Way S.J.R., Lidbury B.A., Banyer J.L. Persistent RRV infection of murine macrophages: an in vitro model for the study of viral relapse and immune modulation during long term infection. Virology 2002, 301:281-292.
124. Weber F.C., Oppel T., Raymond R.W. A mild exanthematous disease seen in the Schouten Islands. Amer. J. Trop. Med. 1946, 26:489-495.
125. Westley-Wise V.J., Beard J.R., Sladden T.J., Dunn T.M., Simpson J. RRV infection on the North Coast of New South Wales. Aust. N.Z. J. Public Health 1996, 20:87-92.
126. Whitehead R.H. Experimental infection of vertebrates with Ross River and Sindbis viruses, two group A arboviruses isolated in Australia. Aust. J. Exp. Biol. Med. Sci. 1969, 47:11-15.
127. Whitehead R.H., Doherty R.L., Domrow R., Standfast H.A., Wetters E.J. Studies of the epidemiology of arthropod-borne virus infections at Mitchell River Mission, Cape York Peninsula, North Queensland. Trans. R. Soc. Trop. Med. Hyg. 1968, 62:439-445.
128. Wilson J.G. The Murray Valley rash. Med. J. Aust. 1957, 2:120-122.
129. Yu S., Aaskov J.G. Development of a candidate vaccine against RRV infection. Vaccine 1994, 12:1118-1124.
130. Zhang W., Heil M., Kuhn R.J., Baker T.S. Heparin binding sites on RRV revealed by electron cryo-microscopy. Virology 2005, 332:511-518.